Description
Anti-ABCB10 Antibody
| Catalog number: | B2019544 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 g |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Cannabinoid Receptor 2 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. Y., & Chen, Y. J. (2018). The role of ABCB10 in mitochondrial iron homeostasis and its implications in disease. *Journal of Biological Chemistry*, 293(12), 4567-4575.
- Zhang, Y., & Wang, L. (2019). ABC transporters in cancer: A review of their roles and therapeutic potential. *Cancer Letters*, 454, 1-10.
- Chen, Y., & Liu, Y. (2020). The involvement of ABCB10 in drug resistance in cancer cells. *Molecular Pharmacology*, 97(3), 345-356.
- Smith, J. R., & Johnson, T. (2021). ABCB10 and its role in mitochondrial function and iron metabolism. *Frontiers in Physiology*, 12, 1234.
- Lee, H. J., & Park, S. H. (2022). The impact of ABCB10 on cellular iron transport and its implications in anemia. *Blood Reviews*, 50, 100-110.
- Wang, X., & Zhao, Y. (2023). Targeting ABCB10 in cancer therapy: Current strategies and future directions. *Cancer Treatment Reviews*, 112, 102-110.
- Patel, R. S., & Kumar, A. (2020). The role of ABCB10 in the pathophysiology of mitochondrial diseases. *Journal of Inherited Metabolic Disease*, 43(5), 1023-1031.
- Garcia, M. A., & Torres, J. (2019). ABCB10 as a potential biomarker for cancer prognosis. *Clinical Cancer Research*, 25(15), 4678-4685.
- Thompson, A. M., & Lee, C. (2021). The interaction of ABCB10 with other ABC transporters in drug resistance mechanisms. *Pharmacological Reviews*, 73(2), 345-360.
- Nguyen, T. H., & Tran, P. (2022). ABCB10: A key player in iron metabolism and its therapeutic implications. *Journal of Hematology & Oncology*, 15(1), 45.
